Loading...
XHKG
2161
Market cap290mUSD
Dec 05, Last price  
2.78HKD
1D
0.36%
1Q
-5.76%
IPO
-2.46%
Name

JBM (Healthcare) Ltd

Chart & Performance

D1W1MN
XHKG:2161 chart
P/E
11.47
P/S
2.89
EPS
0.24
Div Yield, %
1.46%
Shrs. gr., 5y
-1.73%
Rev. gr., 5y
15.44%
Revenues
782m
+20.65%
264,332,000307,515,000381,542,000397,158,000406,139,000520,323,000648,415,000782,292,000
Net income
197m
+51.20%
42,379,00052,459,00041,022,00022,600,00024,620,00057,093,000130,463,000197,261,000
CFO
227m
+18.68%
82,304,00056,914,00038,285,00058,931,00060,014,000145,888,000191,216,000226,937,000
Dividend
Aug 15, 20240.0405 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

JBM (Healthcare) Limited, an investment holding company, develops, manufactures, markets, distributes, and sells healthcare and wellness products in Asia. The company offers consumer healthcare and proprietary Chinese medicines, such as over-the-counter medicines, and medicated and non-medicated solutions, as well as diagnostic devices; and pharmaceutical products. It is also involved in the trading, wholesaling, and retailing of Chinese medicines; trading of medical supplies and pharmaceutical products; and sale of healthcare and herbal products. The company was incorporated in 2020 and is headquartered in Kwun Tong, Hong Kong. JBM (Healthcare) Limited is a subsidiary of JBM Group (BVI) Limited.
IPO date
Feb 05, 2021
Employees
250
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT